We are live on ! Find out more
TENX icon

Tenax Therapeutics
TENX

22 hedge funds and large institutions have $40.1M invested in Tenax Therapeutics in 2015 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 4 increasing their positions, 5 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

12% more capital invested

Capital invested by funds: $35.8M → $40.1M (+$4.22M)

5% more funds holding

Funds holding: 21 → 22 (+1)

20% less repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 5

Holders
22
Holders Change
+1
Holders Change %
+4.76%
% of All Funds
0.58%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
1
Increased
4
Reduced
5
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
AC
Armistice Capital
New York
+$2.9M
2
SM
Sabby Management
Florida
+$311K
3
B
Bailard
California
+$207K
4
BCM
Bourgeon Capital Management
Connecticut
+$104K
5
NFA
Nationwide Fund Advisors
Ohio
+$104K

Top Sellers

Rank Fund Capital Flow
1
CA
Commerzbank Aktiengesellschaft
Germany
-$1.45M
2
RCM
RA Capital Management
Massachusetts
-$830K
3
OM
Opaleye Management
Massachusetts
-$311K
4
Deutsche Bank
Deutsche Bank
Germany
-$207K
5
DCM
DAFNA Capital Management
California
-$104K
Name Holding Trade Value Shares
Change 		Change in
Stake
SM
1
Sabby Management
Florida
$8.84M +$311K +3 +4%
RCM
2
RA Capital Management
Massachusetts
$7.84M -$830K -8 -10%
BC
3
Broadfin Capital
New York
$6.46M – – –
GPP
4
Great Point Partners
Connecticut
$3.64M – – –
AC
5
Armistice Capital
New York
$3.25M +$2.9M +28 +933%
Vanguard Group
6
Vanguard Group
Pennsylvania
$3.22M – – –
OM
7
Opaleye Management
Massachusetts
$1.77M -$311K -3 -15%
BBA
8
Baker Bros. Advisors
New York
$1.38M – – –
CA
9
Commerzbank Aktiengesellschaft
Germany
$984K -$1.45M -14 -61%
Bank of New York Mellon
10
Bank of New York Mellon
New York
$424K – – –
Deutsche Bank
11
Deutsche Bank
Germany
$304K -$207K -2 -40%
Geode Capital Management
12
Geode Capital Management
Massachusetts
$297K – – –
DCM
13
DAFNA Capital Management
California
$261K -$104K -1 -33%
BFA
14
BlackRock Fund Advisors
California
$218K – – –
NFA
15
Nationwide Fund Advisors
Ohio
$197K +$104K +1 +100%
B
16
Bailard
California
$197K +$207K +2 New
BCM
17
Bourgeon Capital Management
Connecticut
$182K +$104K +1 +100%
Dimensional Fund Advisors
18
Dimensional Fund Advisors
Texas
$132K – – –
Verition Fund Management
19
Verition Fund Management
Connecticut
$105K – – –
BIT
20
BlackRock Institutional Trust
California
$104K – – –
Northern Trust
21
Northern Trust
Illinois
$92K – – –
Goldman Sachs
22
Goldman Sachs
New York
$84K – – –
CS
23
Credit Suisse
Switzerland
$43K – – –
UBS Group
24
UBS Group
Switzerland
$22K – – –
BIM
25
BlackRock Investment Management
Delaware
$12K – – –
1
2

TENX Hedge Fund Activity: Q4 2015 in Review

22 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Tenax Therapeutics (TENX) for Q4 2015, worth a combined $40.1M — up 12% from $35.8M a quarter earlier.

Buyers outnumbered sellers: 1 fund opened new TENX positions and 0 closed out — a net gain of 1 holder — while 4 added to existing stakes and 5 trimmed.

The largest buyer was Armistice Capital, adding an estimated $2.9M. The largest seller was Commerzbank Aktiengesellschaft, cutting an estimated $1.45M.

  • 22 institutional investors held Tenax Therapeutics (TENX) as of Q4 2015, up from 21 in Q3 2015.
  • Funds reported $40.1M of Tenax Therapeutics stock for Q4 2015, up 12% quarter-over-quarter.
  • 1 fund opened new Tenax Therapeutics positions in Q4 2015 and 0 closed out, a net change of +1 holder.
  • The largest Tenax Therapeutics buyer in Q4 2015 was Armistice Capital, an estimated $2.9M added.
  • The largest Tenax Therapeutics seller in Q4 2015 was Commerzbank Aktiengesellschaft, an estimated $1.45M sold.

Based on aggregated 13F filings for Q4 2015.